Loading organizations...
Mirador Therapeutics is a precision medicine company developing next-generation therapeutics for immune-mediated diseases. It integrates an end-to-end strategy within immunology and inflammation, efficiently advancing drug candidates from concept to Investigational New Drug applications. Their focus lies in novel treatments for challenging inflammatory and fibrotic conditions, emphasizing rapid, targeted development.
Established in 2023, Mirador Therapeutics was co-founded by a team including CEO Mark C McKenna, leveraging experience from Prometheus Biosciences. The founders identified a critical opportunity to apply advanced precision medicine to unmet needs in immunology and inflammation. This insight drove Mirador's formation, aiming to accelerate impactful, evidence-based therapies.
Mirador Therapeutics serves patients afflicted by immune-mediated, inflammatory, and fibrotic diseases, striving to improve health outcomes. Its vision pushes scientific boundaries to deliver transformative treatments. Moving forward, Mirador aims to redefine the treatment landscape for these complex disorders through its innovative, expedited precision medicine approach.
Mirador has raised $10.0M across 2 funding rounds.
Mirador has raised $10.0M in total across 2 funding rounds.
Mirador has raised $10.0M in total across 2 funding rounds.
Mirador's investors include Core Innnovation Capital, Collaborative Fund, Crosslink Capital, Jump Capital, Nyca Partners, Wicklow Capital, Jay, Seven Seven Six, True Ventures, Y Combinator, Brian Sugar, Ryan Jacoby.
Mirador, Inc. is a financial technology company grounded in Wall Street expertise and powered by advanced data science, delivering consolidated financial reporting, middle office services, offline data management (ODM), and technology solutions primarily to ultra-high-net-worth (U/HNW) wealth management firms, family offices, endowments, foundations, and pensions.[1][2][4][6] Its flagship offerings, such as the RELI platform for alternative investment data processing and K-1 document management, provide real-time, insightful views of assets, liabilities, ownership, and performance to identify opportunities and mitigate risks, often through partnerships with leading tech platforms like Alkymi for AI/ML enhancements.[1][2] Founded in 2015 and employing over 180 professionals across offices in Stamford (HQ), Chicago, Jacksonville, Salt Lake City, Edinburgh, and London, Mirador supports clients globally in North America, South America, EMEA, and Asia Pacific; it was acquired by iCapital in a move enhancing data management for wealth and asset managers.[2]
(Note: Multiple entities share the "Mirador" name, including a separate acquired lending platform from 2013 in Portland, OR, and a 2023 ERP software investor; this profile focuses on the primary wealth tech firm matching the query's description, based on prominence in recent FinTech coverage.)[2][3][7]
Mirador, Inc. was founded in 2015, leveraging Wall Street financial acumen with technology to address complex reporting needs in U/HNW wealth management.[1][2][4] Key details on founders are not specified in available sources, but the company quickly established itself as a specialist in performance reporting, drawing expertise from family offices and wealth-management professionals to form ongoing client partnerships rather than one-off consulting.[2][4] Early evolution centered on proprietary tools like consolidated reporting for alternative investments, expanding to AI/ML integrations (e.g., Alkymi in RELI) and institutional outreach for endowments and pensions; pivotal growth included global office expansions and the iCapital acquisition, which integrated its capabilities into a broader $180.9 billion platform AUM ecosystem.[1][2]
Mirador rides the digital transformation wave in alternative investing and wealth management, where fragmented data across illiquid assets demands AI-driven aggregation and real-time analytics amid rising U/HNW complexity and regulatory scrutiny.[1][2][6] Its timing aligns with surging private market assets ($180.9B+ via iCapital integration) and institutional demand from endowments/pensions, fueled by market forces like low interest rates boosting alternatives and tech adoption post-pandemic.[2] By streamlining offline/alternative data—often siloed in PDFs or emails—Mirador influences the ecosystem as a "WealthTech-as-a-Service" enabler, enhancing decision-making for advisors and reducing operational friction, much like competitors in data aggregation (e.g., BridgeFT) but with deeper Wall Street grounding.[3][4]
Mirador's iCapital acquisition positions it for accelerated scale in institutional and global wealth tech, with roadmaps targeting endowments, foundations, and pensions via enhanced RELI upgrades and AI integrations.[1][2] Trends like AI/ML proliferation in alternatives, rising private assets, and demand for holistic reporting will propel growth, potentially evolving its influence toward full operating systems for wealth managers. As embedded fintech matures, expect Mirador to deepen ecosystem impact, turning data chaos into strategic alpha for U/HNW clients—cementing its role from niche reporter to indispensable platform backbone.[1][2]
Mirador has raised $10.0M across 2 funding rounds. Most recently, it raised $7.0M Series A in November 2015.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Nov 1, 2015 | $7.0M Series A | Core Innnovation Capital | Collaborative Fund, Crosslink Capital, Jump Capital, Nyca Partners, Wicklow Capital |
| Nov 1, 2014 | $3.0M Seed | Collaborative Fund, Jay, Seven Seven Six, True Ventures, Y Combinator, Brian Sugar, Ryan Jacoby, Scott Belsky, Awy Julianto, Bill Ullman, Bruce Gibney, Bruce W., Eric Bunting, George Kenny, Robert Harteveldt, Crosslink Capital, Vesta Corporation, Wicklow Capital |